Validation of a HPLC-UV analytical and bioanalytical method for dexamethasone determination in nanoemulsions, porcine nasal mucosa, and mouse plasma and brain tissue
DOI:
https://doi.org/10.22456/2527-2616.148019Keywords:
Dexamethasone, HPLC, nanotechnology, biological matrices, nasal, plasma, brainAbstract
Dexamethasone (DEX) is a synthetic glucocorticoid widely used in the treatment of inflammatory and autoimmune diseases. However, its clinical efficacy is limited by low water solubility, poor bioavailability, and a high incidence of side effects. To overcome these limitations, nanotechnology-based drug delivery systems, such as nanoemulsions, have emerged as promising alternatives, particularly when combined with nasal administration targeting the treatment of neuroinflammation in the central nervous system. This study describes the validation of an analytical and bioanalytical method using high-performance liquid chromatography with ultraviolet detection (HPLC-UV) for the quantification of DEX active pharmaceutical ingredient (API) in nanoemulsions, porcine nasal mucosa, and mouse plasma and brain tissue. The method was validated according to current regulatory guidelines and was based on a procedure previously described in the 7th edition of the Brazilian Pharmacopoeia (2024). The method demonstrated specificity, with no interference from endogenous components of the matrices. Linearity was confirmed in the range of 0.5 to 10.0 µg mL⁻¹ for standard solutions, nanoemulsion, porcine nasal mucosa, and mouse plasma, and from 1.0 to 10.0 µg mL⁻¹ for mouse brain samples, with correlation coefficients (r) greater than 0.99. The method has also been shown to be precise, accurate and with low matrix effect within regulatory acceptance criteria. These results confirm the method’s reliability for determination of DEX in both nanotechnological and biological matrices. The validated method is intended to support future performance studies of nanotechnology-based formulations for nasal administration of DEX.
Downloads
References
1. Tan G;Yu S;Li J;Pan W. Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone. Int J Biol Macromol, 2017,103,941–7. DOI: https://doi.org/10.1016/j.ijbiomac.2017.05.132
2. Madamsetty VS;Mohammadinejad R;Uzieliene I;Nabavi N;Dehshahri A;García-Couce J;et al. Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems. ACS Biomater Sci Eng, 2022,8,1763–90. DOI: https://doi.org/10.1021/acsbiomaterials.2c00026
3. Dubashynskaya N V.;Bokatyi AN;Skorik YA. Dexamethasone Conjugates: Synthetic Approaches and Medical Prospects. Biomedicines, 2021,9,341. DOI: https://doi.org/10.3390/biomedicines9040341
4. Whitehouse MW. Anti-inflammatory glucocorticoid drugs: reflections after 60 years. Inflammopharmacology, 2011,19,1–19. DOI: https://doi.org/10.1007/s10787-010-0056-2
5. Noreen S;Maqbool I;Madni A. Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic. Eur J Pharmacol, 2021,894,173854. DOI: https://doi.org/10.1016/j.ejphar.2021.173854
6. Moore SG. Intravenous Dexamethasone as an Analgesic: A Literature Review. AANA J, 2018,86,488–93.
7. Meybodi SM;Rabori VS;Salkhorde D;Jafari N;Zeinaly M;Mojodi E;et al. Dexamethasone in COVID-19 treatment: Analyzing monotherapy and combination therapy approaches. Cytokine, 2024,184,156794. DOI: https://doi.org/10.1016/j.cyto.2024.156794
8. Li M;Wang Y;Zhang L;Liu Q;Jiang F;Hou W;et al. Cancer Cell Membrane-Enveloped Dexamethasone Normalizes the Tumor Microenvironment and Enhances Gynecologic Cancer Chemotherapy. ACS Nano, 2023,17,16703–14. DOI: https://doi.org/10.1021/acsnano.3c03013
9. Donovan J;Bang ND;Imran D;Nghia HDT;Burhan E;Huong DTT;et al. Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults. New England Journal of Medicine, 2023,389,1357–67. DOI: https://doi.org/10.1056/NEJMoa2216218
10. Lee A;Blair HA. Dexamethasone Intracanalicular Insert: A Review in Treating Post-Surgical Ocular Pain and Inflammation. Drugs, 2020,80,1101–8. DOI: https://doi.org/10.1007/s40265-020-01344-6
11. Chen N;Xie Q-M;Song S-M;Guo S-N;Fang Y;Fei G-H;et al. Dexamethasone protects against asthma via regulating Hif-1α-glycolysis-lactate axis and protein lactylation. Int Immunopharmacol, 2024,131,111791. DOI: https://doi.org/10.1016/j.intimp.2024.111791
12. Kashyap K;Shukla R. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges. Curr Drug Deliv, 2019,16,887–901. DOI: https://doi.org/10.2174/1567201816666191029122740
13. Keller L-A;Merkel O;Popp A. Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res, 2022,12,735–57. DOI: https://doi.org/10.1007/s13346-020-00891-5
14. Fachel FNS;Nemitz MC;Medeiros-Neves B;Veras KS;Bassani VL;Koester LS;et al. A novel, simplified and stability-indicating high-throughput ultra-fast liquid chromatography method for the determination of rosmarinic acid in nanoemulsions, porcine skin and nasal mucosa. Journal of Chromatography B, 2018,1083,233–41. DOI: https://doi.org/10.1016/j.jchromb.2018.03.020
15. Agência Nacional de Vigilância Sanitária (ANVISA). Farmacopeia Brasileira. 7a edição. Brasil: Agência Nacional de Vigilância Sanitária; 2024.
16. Barbi M da S;Carvalho FC;Kiill CP;Da Silva Barud H;Santagneli SH;Ribeiro SJL;et al. Preparation and Characterization of Chitosan Nanoparticles for Zidovudine Nasal Delivery. J Nanosci Nanotechnol, 2015,15,865–74. DOI: https://doi.org/10.1166/jnn.2015.9180
17. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução RDC n° 166, de 27 de julho de 2017. Dispõe sobre a validação de métodos analíticos e dá outras providências. Brasília, DF: Diário Oficial da União: 2017.
18. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução RDC No 941, de 18 de novembro de 2024. 2024.
19. International Council for Harmonisation for Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH M10 Bioanalytical Method Validation and Study Sample Analysis. 2022.
20. International Conference on Harmonization (ICH). Guidance for industry: Q2(R2) validation of analytical procedures: methodology.
21. Shabir GA. Validation of high-performance liquid chromatography methods for pharmaceutical analysis. J Chromatogr A, 2003,987,57–66. DOI: https://doi.org/10.1016/S0021-9673(02)01536-4
22. Urban MCC;Mainardes RM;Gremião MPD. Development and validation of HPLC method for analysis of dexamethasone acetate in microemulsions. Brazilian Journal of Pharmaceutical Sciences, 2009,45,87–92. DOI: https://doi.org/10.1590/S1984-82502009000100010
23. Yunina D V.;Ageev VP;Zaborovskiy A V.;Tararina LA;Tsaregorodtsev S V.;Kokorev A V.;et al. Method of detection of dexamethasone in biological tissues and its application to assess the local kinetics of this drug. Research Results in Pharmacology, 2023,9,51–7. DOI: https://doi.org/10.18413/rrpharmacology.9.10045
24. Brugnera M;Vicario-de-la-Torre M;Andrés-Guerrero V;Bravo-Osuna I;Molina-Martínez IT;Herrero-Vanrell R. Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release. Pharmaceutics, 2022,14,288. DOI: https://doi.org/10.3390/pharmaceutics14020288
25. Kumar V;Mostafa S;Kayo MW;Goldberg EP;Derendorf H. HPLC determination of dexamethasone in human plasma and its application to an in vitro release study from endovascular stents. Pharmazie, 2006,61,908–11.
26. Nemitz MC;Yatsu FKJ;Bidone J;Koester LS;Bassani VL;Garcia C V.;et al. A versatile, stability-indicating and high-throughput ultra-fast liquid chromatography method for the determination of isoflavone aglycones in soybeans, topical formulations, and permeation assays. Talanta, 2015,134,183–93. DOI: https://doi.org/10.1016/j.talanta.2014.10.062
27. Watanabe E;Kobara Y;Baba K;Eun H. Aqueous acetonitrile extraction for pesticide residue analysis in agricultural products with HPLC−DAD. Food Chem, 2014,154,7–12. DOI: https://doi.org/10.1016/j.foodchem.2013.12.075
28. Niessen WMA;Manini P;Andreoli R. Matrix effects in quantitative pesticide analysis using liquid chromatography–mass spectrometry. Mass Spectrom Rev, 2006,25,881–99. DOI: https://doi.org/10.1002/mas.20097
29. Instituto Nacional de Metrologia Q e T (INMETRO). Orientação sobre Validação de Métodos Analíticos – DOQ-CGCRE-008 Revisão 9. 2020.
Downloads
Published
Versions
- 30-03-2026 (2)
- 18-07-2025 (1)
How to Cite
Issue
Section
License
Copyright (c) 2025 Drug Analytical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.
